本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

18.15
-0.2400-1.31%
盘前:18.680.5312+2.93%04:22 EDT
成交量:80.30万
成交额:1,459.59万
市值:11.10亿
市盈率:-11.05
高:18.61
开:18.29
低:17.96
收:18.39
52周最高:35.34
52周最低:12.12
股本:6,113.68万
流通股本:4,252.58万
量比:0.77
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
净资产收益率:-10.70%
总资产收益率:-8.80%
市净率:1.20
市盈率(LYR):-9.90

数据加载中...

2024/03/08

重要事件披露

Form 8-K - Current report
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]